Healthcare Revenue Cycle Management Market – Global Industry Analysis and Forecast (2023-2029)

Healthcare Revenue Cycle Management Market size is projected to reach US$ 290.61 Bn at the end of the forecast period at a CAGR of 12.62%. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.Healthcare Revenue Cycle Management MarketTo know about the Research Methodology :- Request Free Sample Report

Healthcare Revenue Cycle Management Market Overview:

Global market growth is primarily driven by increasing healthcare expenditures in both developed and developing countries such as China, U.S., Japan, and Germany. Other factors such as rising complications in the revenue data management in the hospitals and lessen billing errors in the hospitals, drive the market for healthcare revenue Cycle management through the forecast period. Service market had the highest share in 2022. This market is driven due to increased usage of proper software, and implementation of different solutions for the processes such as, e-prescribing systems and electronic medical records. Other factors including high influence form big data analytics, and rising investment from the government for the development of software in the field of healthcare to provide good service also drive the market. Government implementations including Medicare, Medicaid, and e-Health also drive the market for services market The integrated segment had the highest market share in 2022. The factors such as a change in the systems from volume to value-based transactions and increasing need of software’s for the diagnosis, drive the market for Healthcare Revenue Cycle Management through the forecast period. Integrated products provide diverse applications including patient scheduling, health records, and billing. These applications create an elevated level of interest in buyers to purchase integrated products in healthcare revenue cycle management The cloud-based segment had the highest market share in 2022. The factors such as increasing demand for the internet of things in each department of the healthcare sector, and a rising need for the single platform to perform all the activities of the healthcare sectors drive the market through the forecast period. As the cloud-based deployment is less expensive and highly convenient for the implementation compared to the on-premise, the market is expected to grow through 2029. Physicians segment had the highest market share in 2022. The factors such as, the increasing number of hospitals, rising need for the advice from the physicians, rising incidences of emergencies in the hospitals, and increasing government fund on the hospitals and other clinical facilities drive the market for Healthcare Revenue Cycle Management through the forecast period.

Key Highlights:

Global Market analysis and forecast, in terms of value. Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Market Global Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. The Global Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. Global Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Market are also profiled.

Regional Insights

North America had the highest market share in 2022. The factors such as strict regulations from the government regarding proper billing and tax payment, and safeguarding the clinical data drive the market for healthcare revenue cycle management. Implementation of Care Act by U.S. government is the primary driving factor the market of healthcare revenue cycle management through the forecast period.

Healthcare Revenue Cycle Management Market Scope: Inquire before buying

Global Healthcare Revenue Cycle Management Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 126.47 Bn.
Forecast Period 2023 to 2029 CAGR: 12.62% Market Size in 2029: US $ 290.61 Bn.
Segments Covered: by Deployment On-Premise Cloud-Based Web-Based Others
by Component Software Services
by Products Standalone Integrated Others
by End-User Hospitals Laboratories Physicians Others

Healthcare Revenue Cycle Management Market, by Region

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Key Player

1. Allscripts 2. Cerner 3. GE Healthcare 4. McKesson 5. Alleviant 6. Athenahealth 7. Avadyne Health 8. MedData 9. MediRevv 10. Navigant Cymetrix 11. nThrive 12. OPTUM 13. SourceMed 14. ZirMed

Frequently Asked Questions:

1. Which region has the largest share in Global Healthcare Revenue Cycle Management Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Healthcare Revenue Cycle Management Market? Ans: The Global market is expected to grow at a CAGR of 12.62% during forecast period 2023-2029. 3. What is scope of the Global Healthcare Revenue Cycle Management market report? Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Healthcare Revenue Cycle Management market? Ans: The important key players in the Global market are – Allscripts, Cerner, GE Healthcare, McKesson, Alleviant, Athenahealth, Avadyne Health, MedData, MediRevv, Navigant Cymetrix, nThrive, OPTUM, SourceMed, and ZirMed 5. What is the study period of this market? Ans: The Global market is studied from 2022 to 2029.
Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary Paid Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global Healthcare Revenue Cycle Management Market overview 2.1.1. By Products 2.1.2. By Component 2.1.3. By Deployment 2.1.4. By End-Use Chapter 3 Global Healthcare Revenue Cycle Management Market Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers Rising incidences of hospitalizations 3.2.2. Market Restraints High costs associated with RCM deployment 3.3. Market share analysis 3.3.1. By Products 3.3.2. By Component 3.3.3. By Deployment 3.3.4. By End-Use 3.4. Competitive analysis 3.4.1. Key strategic initiatives 3.4.2. Regional presence 3.4.3. Product overview 3.5. Porter’s analysis 3.6. PESTEL analysis Chapter 4 Healthcare Revenue Cycle Management Market, By Products 4.1. Key segment trends 4.2. Standalone 4.2.1. Market size, by region, 2022-2029 4.3. Integrated 4.3.1. Market size, by region, 2022-2029 4.4. Others 4.4.1. Market size, by region, 2022-2029 Chapter 5 Healthcare Revenue Cycle Management Market, By Component 5.1. Key segment trends 5.2. Software 5.2.1. Market size, by region, 2022-2029 5.3. Services 5.3.1. Market size, by region, 2022-2029 Chapter 6 Healthcare Revenue Cycle Management Market, By Deployment 6.1. Key segment trends 6.2. On-Premise 6.2.1. Market size, by region, 2022-2029 6.3. Cloud-Based 6.3.1. Market size, by region, 2022-2029 6.4. Web-Based 6.4.1. Market size, by region, 2022-2029 6.5. Others 6.5.1. Market size, by region, 2022-2029 Chapter 7 Healthcare Revenue Cycle Management Market, By End-Use 7.1. Key segment trends 7.2. Hospitals 7.2.1. Market size, by region, 2022-2029 7.3. Laboratories 7.3.1. Market size, by region, 2022-2029 7.4. Physicians 7.4.1. Market size, by region, 2022-2029 7.5. Others 7.5.1. Market size, by region, 2022-2029 Chapter 8 Healthcare Revenue Cycle Management Market, By Region 8.1. Key regional trends 8.2. North America 8.2.1. Market size, by country, 2022-2029 8.2.2. Market size, by products, 2022-2029 8.2.3. Market size, by component, 2022-2029 8.2.4. Market size, by deployment, 2022-2029 8.2.5. Market size, by end-use, 2022-2029 8.3. U.S. 8.3.1. Market size, by products, 2022-2029 8.3.2. Market size, by component, 2022-2029 8.3.3. Market size, by deployment, 2022-2029 8.3.4. Market size, by end-use, 2022-2029 8.4. Canada 8.4.1. Market size, by products, 2022-2029 8.4.2. Market size, by component, 2022-2029 8.4.3. Market size, by deployment, 2022-2029 8.4.4. Market size, by end-use, 2022-2029 8.5. Europe 8.5.1. Market size, by country, 2022-2029 8.5.2. Market size, by products, 2022-2029 8.5.3. Market size, by component, 2022-2029 8.5.4. Market size, by deployment, 2022-2029 8.5.5. Market size, by end-use, 2022-2029 8.6. Germany 8.6.1. Market size, by products, 2022-2029 8.6.2. Market size, by component, 2022-2029 8.6.3. Market size, by deployment, 2022-2029 8.6.4. Market size, by end-use, 2022-2029 8.7. UK 8.7.1. Market size, by products, 2022-2029 8.7.2. Market size, by component, 2022-2029 8.7.3. Market size, by deployment, 2022-2029 8.7.4. Market size, by end-use, 2022-2029 8.8. France 8.8.1. Market size, by products, 2022-2029 8.8.2. Market size, by component, 2022-2029 8.3. Market size, by deployment, 2022-2029 8.8.4. Market size, by end-use, 2022-2029 8.9. Spain 8.9.1. Market size, by products, 2022-2029 8.9.2. Market size, by component, 2022-2029 8.9.3. Market size, by deployment, 2022-2029 8.9.4. Market size, by end-use, 2022-2029 8.10. Italy 8.10.1. Market size, by products, 2022-2029 8.10.2. Market size, by component, 2022-2029 8.10.3. Market size, by deployment, 2022-2029 8.10.4. Market size, by end-use, 2022-2029 8.11. Sweden 8.11.1. Market size, by products, 2022-2029 8.11.2. Market size, by component, 2022-2029 8.11.3. Market size, by deployment, 2022-2029 8.11.4. Market size, by end-use, 2022-2029 8.12. Asia Pacific 8.12.1. Market size, by country, 2022-2029 8.12.2. Market size, by products, 2022-2029 8.12.3. Market size, by component, 2022-2029 8.12.4. Market size, by deployment, 2022-2029 8.12.5. Market size, by end-use, 2022-2029 8.13. India 8.13.1. Market size, by products, 2022-2029 8.13.2. Market size, by component, 2022-2029 8.13.3. Market size, by deployment, 2022-2029 8.13.4. Market size, by end-use, 2022-2029 8.14. China 8.14.1. Market size, by products, 2022-2029 8.14.2. Market size, by component, 2022-2029 8.14.3. Market size, by deployment, 2022-2029 8.14.4. Market size, by end-use, 2022-2029 8.15. Japan 8.15.1. Market size, by products, 2022-2029 8.15.2. Market size, by component, 2022-2029 8.15.3. Market size, by deployment, 2022-2029 8.15.4. Market size, by end-use, 2022-2029 8.16. Australia 8.16.1. Market size, by products, 2022-2029 8.16.2. Market size, by component, 2022-2029 8.16.3. Market size, by deployment, 2022-2029 8.16.4. Market size, by end-use, 2022-2029 8.17. Latin America 8.17.1. Market size, by country, 2022-2029 8.17.2. Market size, by products, 2022-2029 8.17.3. Market size, by component, 2022-2029 8.17.4. Market size, by deployment, 2022-2029 8.17.5. Market size, by end-use, 2022-2029 8.18. Argentina 8.18.1. Market size, by products, 2022-2029 8.18.2. Market size, by component, 2022-2029 8.18.3. Market size, by deployment, 2022-2029 8.18.4. Market size, by end-use, 2022-2029 8.19. Brazil 8.19.1. Market size, by products, 2022-2029 8.19.2. Market size, by component, 2022-2029 8.19.3. Market size, by deployment, 2022-2029 8.19.4. Market size, by end-use, 2022-2029 8.20. Mexico 8.20.1. Market size, by products, 2022-2029 8.20.2. Market size, by component, 2022-2029 8.20.3. Market size, by deployment, 2022-2029 8.20.4. Market size, by end-use, 2022-2029 8.21. Middle East and Africa 8.21.1. Market size, by country, 2022-2029 8.21.2. Market size, by products, 2022-2029 8.21.3. Market size, by component, 2022-2029 8.21.4. Market size, by deployment, 2022-2029 8.21.5. Market size, by end-use, 2022-2029 8.22. South Africa 8.22.1. Market size, by products, 2022-2029 8.22.2. Market size, by component, 2022-2029 8.22.3. Market size, by deployment, 2022-2029 8.22.4. Market size, by end-use, 2022-2029 8.23. Saudi Arabia 8.23.1. Market size, by products, 2022-2029 8.23.2. Market size, by component, 2022-2029 8.23.3. Market size, by deployment, 2022-2029 8.23.4. Market size, by end-use, 2022-2029 Chapter 9 Consolidations 9.1. Mergers and Acquisitions 9.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 9.3. Patent Analysis Chapter 10 Company Profiles 10.1. Allscripts 10.1.1. Company overview 10.1.2. Key financials 10.1.3. Product landscape 10.1.4. Strategic initiatives 10.1.5. SWOT analysis 10.2. Cerner 10.2.1. Company overview 10.2.2. Key financials 10.2.3. Product landscape 10.2.4. Strategic initiatives 10.2.5. SWOT analysis 10.3. GE Healthcare 10.3.1. Company overview 10.3.2. Key financials 10.3.3. Product landscape 10.3.4. Strategic initiatives 10.3.5. SWOT analysis 10.4. McKesson 10.4.1. Company overview 10.4.2. Key financials 10.4.3. Product landscape 10.4.4. Strategic initiatives 10.4.5. SWOT analysis 10.5. Alleviant 10.5.1. Company overview 10.5.2. Key financials 10.5.3. Product landscape 10.5.4. Strategic initiatives 10.5.5. SWOT analysis 10.6. athenahealth 10.6.1. Company overview 10.6.2. Key financials 10.6.3. Product landscape 10.6.4. Strategic initiatives 10.6.5. SWOT analysis 10.7. Avadyne Health 10.7.1. Company overview 10.7.2. Key financials 10.7.3. Product landscape 10.7.4. Strategic initiatives 10.7.5. SWOT analysis 10.8. MedData 10.8.1. Company overview 10.8.2. Key financials 10.8.3. Product landscape 10.8.4. Strategic initiatives 10.8.5. SWOT analysis 10.9. MediRevv 10.9.1. Company overview 10.9.2. Key financials 10.9.3. Product landscape 10.9.4. Strategic initiatives 10.9.5. SWOT analysis 10.10. Navigant Cymetrix 10.10.1. Company overview 10.10.2. Key financials 10.10.3. Product landscape 10.10.4. Strategic initiatives 10.10.5. SWOT analysis 10.11. nThrive 10.11.1. Company overview 10.11.2. Key financials 10.11.3. Product landscape 10.11.4. Strategic initiatives 10.11.5. SWOT analysis 10.12. OPTUM 10.12.1. Company overview 10.12.2. Key financials 10.12.3. Product landscape 10.12.4. Strategic initiatives 10.12.5. SWOT analysis 10.13. SourceMed 10.13.1. Company overview 10.13.2. Key financials 10.13.3. Product landscape 10.13.4. Strategic initiatives 10.13.5. SWOT analysis 10.14. ZirMed 10.14.1. Company overview 10.14.2. Key financials 10.14.3. Product landscape 10.14.4. Strategic initiatives 10.14.5. SWOT analysis 10.14.Cognizant Technology Solutions 10.15. CareCloud 10.16. Conifer Health Solutions 10.17. Dell 10.18. Emdeon 10.19. Etransmedia 10.20. Experian 10.21. EPIC Systems 10.22. Gebbs Healthcare Solutions 10.23. Experian 10.24. R1 RCM 10.25. Constellation Software 10.26. The SSI Group 10.27. Nthrive.